Good MorningEquity markets continue to tread water as investors and traders wait on the next FOMC policy statement. The FOMC is not expected to hike rates next week, but it will remain hawkish and may surprise the market with its rhetoric. The takeaway is that interest rates will most likely remain high for an indefinite amount of time, which will have a bearing on stocks. With rates on treasuries above the S&P 500 dividend average, they pose a headwind to equity prices.
The market may remain in a holding pattern for the summer. If the S&P 500 can not get above the 4,300 level next week, it will be the top of a trading range that could dominate price action for several years. In that scenario, investors must be vigilant and use market dips to build positions in high-quality stocks. Featured: Doing This Wins 85% Of Market Trades (Investing Daily) 
|
Markets | | |
Over the last five weeks, MicroVision (NASDAQ: MVIS) stock is up almost 300%, marching in an almost straight line upwards, with only two red days since the rally started.
The stock has become the subject of a short squeeze; social media hype and the company's past involvements in augmented realit... Read the Full Story |
|
From Our PartnersSkyrocketing national debt, persistent inflationary pressures, and a government struggling to implement effective measures all serve as clear signals of an impending collapse. The implications of such an event would be nothing short of catastrophic.
By clicking link you are subscribing to The Darwin Investor Network and may receive up to 2 additional free bonus subscriptions. Unsubscribing is easy. Full disclosures found here.
| | | | Click here to download the free report |
|
Stocks | | |
Despite rising mortgage rates and a slightly cooling housing market, homebuilding stocks like Lennar (NYSE: LEN) and KB Homes (NYSE: KBH) are ripping higher and outperforming the S&P 500.
The sector was buoyed by positive earnings results from the likes of Redfin (NASDAQ: RDFN), Toll Brothers... Read the Full Story |
|
Stocks | | |
The story of Netflix Inc.'s (NASDAQ: NFLX) turnaround potential is getting investors' attention. The streamer's stock is up 23.71% in the past month, gapping up on May 18 following news that it has almost 5 million users of its advertising-supported service, and more than a quarter of new signups ... Read the Full Story |
|
From Our PartnersGraphite - not lithium - is the largest component of lithium-ion batteries used in electric vehicles. That's why 97 more graphite mines will be needed by 2035 just to keep up with battery demand for the $7 trillion EV market. | | | | See who could benefit from skyrocketing graphite demand |
|
Markets | | | China’s exports fell 7.5% from a year earlier in May and imports were down 4.5%, adding to signs an economic rebound following the end of anti-virus controls is slowing as global demand weakens under pressure from higher interest rates.Exports slid to $283.5 billion, reversing from April’s unexpecte... Read the Full Story |
|
Markets | | | The global economy must steer through a precarious recovery this year and next as inflation keeps dragging on household spending and higher interest rates weigh on growth, banks and markets. That was the takeaway Wednesday from the latest economic outlook by the Paris-based Organization for Economic... Read the Full Story |
|
From Our PartnersThe demand for precious metals, especially gold, is growing due to technological advancements!
Canada's gold mining industry is expected to rise with better technology to access new deposits and increase recovery rates.
We know a company well positioned to meet this demand. This Gold stock has strategically positioned projects to capitalize on the region's mineral wealth.
| | Get Symbol Now! |
|
Markets | | | Global prices for wheat and corn soared Tuesday after a major dam in Ukraine collapsed, renewing market fears about the fragility of the country's ability to ship food to Africa, the Middle East and parts of Asia as it fights a war with Russia.Wheat prices gained 2.4% in early trading Tuesday on the... Read the Full Story |
|
Markets | | | The European economy contracted slightly at the end of last year and beginning of 2023, revised figures showed Thursday, underlining the impact of the loss of Russian natural gas and high inflation on consumer spending.Economic output in the 20 countries that use the euro currency dropped 0.1% in bo... Read the Full Story |
|
Markets | | | The global economy is likely slowing sharply this year, hobbled by high interest rates, the repercussions of Russia's invasion of Ukraine and the lingering effects of the coronavirus pandemic.That's the latest outlook of the World Bank, a 189-country anti-poverty agency, which estimates that the int... Read the Full Story |
|
Markets | | |
Campbell Soup Company (NYSE: CPB) fell more than 6.5% following its Q3 report for no good reason. The company’s results were better than expected, and the guidance was reaffirmed and might be considered cautious. The news was no catalyst for the rally but also not a spark to send investors r... Read the Full Story |
|
Markets | | |
If you’ve been looking for a good time to get into Ollie’s Bargain Outlook (NASDAQ: OLLI), that time could be now. The stock is pulling back after a solid report that brings nothing but good news for investors. The takeaways include shifting trends and accelerating purchasing habits, i... Read the Full Story |
|
Thursday's Early Bird Stock Of The Day NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases in the United States. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a nanoparticle technology platform. The company's product candidates include NEXI-001, an allogeneic cell therapy, which is in Phase I/II clinical trials for the treatment of patients with acute myeloid leukemia; NEXI-002, an autologous cell therapy that is in Phase I/II clinical trials for the treatment of patients with relapsed and/or refractory in multiple myeloma; and NEXI-003, a product candidate targeted against HPV related cancers, which is in Phase I/II clinical trials. It provides NEXI-004 which is in preclinical stage for EBV related diseases; and NEXI005 designs for patient with specific targets for solid tumors. NexImmune, Inc. was incorporated in 2011 and is headquartered in Gaithersburg, Maryland. | | View Today's Stock Pick |
|
